Next-generation biomechanics platform launched alongside the announcement of new strategic board appointments supporting Movetru’s global commercial expansion
BELFAST based sports technology company Movetru is ending the old year by ringing in the new.
Movetru, dedicated to reducing the risk of sports injury and advancing athletic performance, has strengthened its leadership team with two strategic board appointments as the company prepares for accelerated growth in Ireland, the UK, and the US.
Gareth Quinn, a Northern Ireland based entrepreneur and sports tech founder, has joined Movetru as a Non-Executive Director.
In addition, Dr. Chris Rumana, a leading US neurosurgeon and the Chairperson of Belfast medical-technology firm Axial 3D, has been appointed as Chairperson of Movetru.
The appointments were announced at a launch event for Movetru’s complete new system – a wearable device paired with an AI-powered app that delivers instant, on-field biomechanical insights.
Designed for athletes, coaches, and teams, the platform provides the depth of laboratory-grade biomechanics in a fully mobile, accessible format, empowering performance optimisation and reducing the risk of injury.
The showcase event in their Sports Innovation Lab was attended by investors, athletes, supporters and sporting organisations from across Ireland, the UK, and the US.
Among them, Antrim hurling legend, Neil McManus, a Gaelic Players Association board member, said: “It was a pleasure to be in attendance at the Movetru launch, the sky is the limit for this company. From a GAA perspective I know how impactful this can be for athletes, there are 4,000 inter-county players who will all benefit from Movetru.”
Ireland rugby 7’s player Niamh Marley added: “Movetru really helped during my third ACL injury. I knew I wanted any percentage gain I could to make sure I could make it back to the top level.
“It is an amazing experience and to say I was treated with the highest standard is an understatement. Movetru is something I would advise everybody to use.”
Welcoming the new board appointments, Movetru founder and CEO Naomi McGregor said: “We are so excited to be here with our athletes, investors, supporters and team to celebrate all of the things that come together to make Movetru happen.
This has been a phenomenal event and we are so excited to hit 2026 with a bang.”
Appointee Gareth Quinn responded: “I see Movetru becoming the standard for movement intelligence in sport. As we grow, our technology will integrate even deeper into training, rehab and performance workflows, while our go-to-market strategy unlocks new sports, new partnerships and that global scale.”
The board appointments follow on from an investment round earlier this year led by Two Magnolias (UK) and supported by an international syndicate of investors across the UK, Ireland, and the United States, including US investors IAG Capital.
These appointments bring a powerful combination of commercial experience, clinical expertise, and strategic insight.
Their combined knowledge will play a pivotal role in guiding Movetru through its next phase of market expansion and supporting the company’s go-to-market strategy.
Dr Chris Rumana commented: “Naomi herself is the perfect advocate, with her history, for helping athletes reduce injury risk and avoiding people being taken out of the sports that they love.”
The announcement of these two key positions were made at the Movetru Product Launch.
Movetru, celebrated the official launch of its technology on Thursday evening, December 4th, at a showcase event in their Sports Innovation Lab attended by investors, athletes, supporters, and sporting organisations from across Ireland, the UK, and the US.
Athletes, coaches, and sports professionals can now book on-field and in-lab screenings and order Movetru devices via the official website movetru.io
New board member Gareth Quinn and Movetru CEO Naomi McGregor
Photography by Brendan Gallagher Photography
